Bioactive rather than total IGF-I is involved in acute responses to nutritional interventions in CAPD patients

Nephrology Dialysis Transplantation

Volumn 25, Issue 3, 2010, Pages 940-946

  Brugts, Michael P ^a   Tjiong, Hoey Lan ^a   Rietveld, Trinet ^a   Wattimena, Josias L ^a   Van Den Berg, Jacobus W ^a   Fieren, Marien W ^a   Janssen, J A M J L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CAPD; IGF I bioactivity; Nutrition; Total IGF I

Indexed keywords

AMINO ACID MIXTURE; GLUCOSE; INSULIN; NUTRINEAL; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BIOASSAY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; FEEDING; FEMALE; GLUCOSE INTAKE; HEMODIALYSIS PATIENT; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; IMMUNOASSAY; KINASE RECEPTOR ACTIVATION ASSAY; MALE; MALNUTRITION; MEAL; PRIORITY JOURNAL;

ADULT; AGED; AMINO ACIDS; CROSS-OVER STUDIES; DIALYSIS SOLUTIONS; FEMALE; GLUCOSE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FAILURE, CHRONIC; MALE; MALNUTRITION; MIDDLE AGED; NUTRITION THERAPY; NUTRITIONAL STATUS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;

EID: 77649200167     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp576     Document Type: Article

References (37)

1. Kalantar-Zadeh K, Ikizler TA, Block G, et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003; 42: 864-881
2. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994; 15: 80-101
3. Ketelslegers JM, Maiter D, Maes M, et al. Nutritional regulation of insulin-like growth factor-I. Metabolism 1995; 44: 50-57
4. Rabkin R. Nutrient regulation of insulin-like growth factor-I. Miner Electrolyte Metab 1997; 23: 157-160
5. Sanaka T, Shinobe M, Ando M, et al. IGF-I as an early indicator of malnutrition in patients with end-stage renal disease. Nephron 1994; 67: 73-81
6. Jacob V, Le Carpentier JE, Salzano S, et al. IGF-I, a marker of un-dernutrition in hemodialysis patients. Am J Clin Nutr 1990; 52: 39-44
7. Lindgren BF, Friis K, Ericsson F. Insulin-like growth factor I correlates with protein intake estimated from the normalized protein cata-bolic rate in hemodialysis patients. Am J Nephrol 2000; 20: 255-262
8. Garibotto G PN, Dertenois L. Nutritional Management of Renal Disease. Chapter 1; Protein and Amino Acid Metabolism in Renal Failure. Philadelphia: Lippincott Williams & Wilkins, 2004
9. Tonshoff B, Eden S, Weiser E, et al. Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia. Kidney Int 1994; 45: 1085-1092
10. Frystyk J, Ivarsen P, Skjaerbaek C, et al. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int 1999; 56: 2076-2084
11. Phillips LS, Kopple JD. Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function. Metabolism 1981; 30: 1091-1095
12. Chen JW, Ledet T, Orskov H, et al. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab 2003; 284: E1149-E1155
13. Sadick MD, Intintoli A, Quarmby V, et al. Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays. J Pharm Biomed Anal 1999; 19: 883-891
14. Laursen LS, Kjaer-Sorensen K, Andersen MH, et al. Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and-5. Mol Endocrinol 2007; 21: 1246-1257
15. Tjiong HL, van den Berg JW, Wattimena JL, et al. Dialysate as food: combined amino acid and glucose dialysate improves protein anabo-lism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol 2005; 16: 1486-1493
16. Tjiong HL, Rietveld T, Wattimena JL, et al. Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding. Clin J Am Soc Nephrol 2007; 2: 74-80
17. Brugts MP, Ranke MB, Hofland LJ, et al. Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays. J Clin En-docrinol Metab 2008; 93: 2539-2545
18. Elmlinger MW, Kuhnel W, Weber MM, et al. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med 2004; 42: 654-664
19. Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987; 11: 8-13
20. Smith WJ, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-bind-ing proteins in children and adults. J Clin Endocrinol Metab 1995; 80: 443-449
21. Baxter RC, Cowell CT. Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab 1987; 65: 432-440
22. Busby WH, Snyder DK, Clemmons DR. Radioimmunoassay of a 26, 000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. J Clin Endocrinol Metab 1988; 67: 1225-1230
23. Suikkari AM, Koivisto VA, Rutanen EM, et al. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988; 66: 266-272
24. Snyder DK, Clemmons DR. Insulin-dependent regulation of insulinlike growth factor-binding protein-1. J Clin Endocrinol Metab 1990; 71: 1632-1636
25. Thissen JP, Pucilowska JB, Underwood LE. Differential regulation of insulin-like growth factor I (IGF-I) and IGF binding protein-1 messenger ribonucleic acids by amino acid availability and growth hormone in rat hepatocyte primary culture. Endocrinology 1994; 134: 1570-1576
26. Bar RS, Boes M, Clemmons DR, et al. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and en-dothelial cell IGF-binding proteins in the rat heart. Endocrinology 1990; 127: 497-499
27. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34
28. Pupim LB, Flakoll PJ, Brouillette JR, et al. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemo-dialysis patients. J Clin Invest 2002; 110: 483-492
29. Millward DJ, Rivers JP. The nutritional role of indispensable amino acids and the metabolic basis for their requirements. Eur J Clin Nutr 1988; 42: 367-393
30. Quevedo MR, Price GM, Halliday D, et al. Nitrogen homoeostasis in man: diurnal changes in nitrogen excretion, leucine oxidation and whole body leucine kinetics during a reduction from a high to a moderate protein intake. Clin Sci (Lond) 1994; 86: 185-193
31. Castaneda C, Dolnikowski GG, Dallal GE, et al. Protein turnover and energy metabolism of elderly women fed a low-protein diet. Am J Clin Nutr 1995; 62: 40-48
32. Donahue SP, Phillips LS. Response of IGF-1 to nutritional support in malnourished hospital patients: a possible indicator of short-term changes in nutritional status. Am J Clin Nutr 1989; 50: 962-969
33. Blum WF, Ranke MB, Kietzmann K, et al. Growth hormone resistance and inhibition ofsomatomedin activitybyexcess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 1991; 5: 539-544
34. TonshoffB.BlumWF, WingenAM, et al. Seruminsulin-likegrowthfac-tors (IGFs) and IGF binding proteins1,2,and3inchildren with chronic renal failure: relationship to height and glomerular filtration rate. The EuropeanStudyGroup forNutritionalTreatmentofChronic Renal Failure in Childhood. J Clin Endocrinol Metab 1995; 80: 2684-2691
35. Nanba K, Nagake Y, Miyatake N, et al. Relationships of serum levels of insulinlike growth factors with indices of bone metabolism and nutritional conditionsin hemodialysis patients. Nephron 2001; 89: 145-152
36. Powell DR, Liu F, Baker BK, et al. Effect of chronic renal failure and growth hormone therapy on the insulin-like growth factors and their binding proteins. Pediatr Nephrol 2000; 14: 579-583
37. Clemmons DR. IGF-I assays: current assay methodologies and their limitations. Pituitary 2007; 10: 121-128